| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/10/1999 | CA2322684A1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | CA2322665A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | CA2322615A1 Virus preparations and methods |
| 09/10/1999 | CA2322450A1 Formulations having an antiviral action |
| 09/10/1999 | CA2322337A1 Enhancement of immunity by intranasal inoculation of il-12 |
| 09/10/1999 | CA2322336A1 Il-12 stimulation of neonatal immunity |
| 09/10/1999 | CA2322199A1 Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 09/10/1999 | CA2320757A1 New use |
| 09/10/1999 | CA2318896A1 Fungicide composition comprising a benzoylphenylurea |
| 09/10/1999 | CA2264970A1 Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| 09/09/1999 | DE19809304A1 Formulierungen mit antiviraler Wirkung Formulations having antiviral activity |
| 09/08/1999 | EP0940141A2 Use of PKC inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection |
| 09/08/1999 | EP0940081A1 Combinations of active agents and disinfectants, preservatives and antiseptics containing same |
| 09/08/1999 | EP0939835A1 Compositions and methods for treating viral infections |
| 09/08/1999 | EP0939818A1 Recombinant toxin fragments |
| 09/08/1999 | EP0939802A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 09/08/1999 | EP0939766A2 Synthesis of soluble beta-sheet forming peptides |
| 09/08/1999 | EP0939760A2 1-thiogalactose derivatives |
| 09/08/1999 | EP0939759A2 Saccharide derivatives |
| 09/08/1999 | EP0939754A2 N-oxy-naphthalimides as antibacterial agents |
| 09/08/1999 | EP0939656A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 09/08/1999 | EP0939654A1 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 09/08/1999 | EP0939650A1 Vaccines |
| 09/08/1999 | EP0939646A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/08/1999 | EP0939641A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 09/08/1999 | EP0939633A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 09/08/1999 | EP0939631A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 09/08/1999 | EP0939625A1 2-cyclopenten-1-one as an inducer of hsp70 |
| 09/08/1999 | EP0939613A1 Mouthwash comprising calcium and phosphate ions in supersaturated solution |
| 09/08/1999 | EP0939590A1 Delivery of therapeutic gene products by intestinal cell expression |
| 09/08/1999 | EP0939589A2 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
| 09/08/1999 | EP0706393B1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 09/08/1999 | EP0671943B1 Use of enzymes, especially bromelain, in the treatment of non-infectious diarrhoea |
| 09/08/1999 | EP0656906B1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 09/08/1999 | EP0592643B1 Pleuromutilin derivatives |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1228085A New polycyclic 2,3-phthalazine derivatives and their use |
| 09/08/1999 | CN1228083A Arylsulfonylamino hydroxamic acid derivatives |
| 09/08/1999 | CN1228080A Novel immunotherapeutic agents and their use in production of cytokine levels |
| 09/08/1999 | CN1228028A Use of histamine for therapeutic purposes |
| 09/08/1999 | CN1228026A Combinations comprising VX 478, zidovudine, FTC and/or 3TC for use in treatment of HIV |
| 09/08/1999 | CN1227842A Penems and their derivatives |
| 09/07/1999 | US5948918 Plant extracts |
| 09/07/1999 | US5948884 Cyclic peptide with substituents on the methylene group of sarcosine in position 3 of cyclosporin; viricide against human immunodeficiency virus without immunosuppressive effect |
| 09/07/1999 | US5948790 Retroviral protease inhibitors |
| 09/07/1999 | US5948778 Difluoro statone antiviral analogs |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948755 Cyclosporin compound, its preparation and the pharmaceutical compositions which contain it |
| 09/07/1999 | US5948753 Cyclohexapeptidyl propanolamine compounds |
| 09/07/1999 | US5948693 Solid phase synthesis of immunosuppressive agents |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
| 09/07/1999 | US5948436 Protease inhibitor |
| 09/07/1999 | US5948413 Method and vaccine for treatment of pythiosis insidiosi in humans and lower animals |
| 09/07/1999 | US5948412 Vaccine for Moraxella catarrhalis |
| 09/07/1999 | US5948411 Varicella virus; disaccharide, sodium glutamate, gelatin free of ca and mg cations |
| 09/07/1999 | US5948410 Animal cell culture |
| 09/07/1999 | US5948408 DNA encoding bactericidal/permeability-increasing proteins |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | CA2138765C Recombinant haemophilus influenzae protein and nucleotide sequence encoding same |
| 09/07/1999 | CA2014884C 5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of aids |
| 09/07/1999 | CA2006119C Anti-aids viral agents and anticancer action |
| 09/07/1999 | CA2004166C Implant for use in bone surgery |
| 09/07/1999 | CA1340721C 1,4-dihydro-quinoline-and naphthyridine-3-carboxylic acid antibacterial agents |
| 09/02/1999 | WO1999043841A1 Self-replicating vector for dna immunization against hiv |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | WO1999043700A1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/02/1999 | WO1999043699A1 Streptogramin derivatives, preparation method and compositions containing same |
| 09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 09/02/1999 | WO1999043691A1 2'-fluoronucleosides |
| 09/02/1999 | WO1999043671A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials |
| 09/02/1999 | WO1999043349A1 Mucosal microparticle conjugate vaccine |
| 09/02/1999 | WO1999043344A2 Matrix protein compositions for wound healing |
| 09/02/1999 | WO1999043338A1 Antibacterial drugs, methods for their design and methods for their use |
| 09/02/1999 | WO1999043337A1 Cyclic peptide antifungal agents |
| 09/02/1999 | WO1999043322A1 Method for the treatment of pain, including chronic and female specific pain |
| 09/02/1999 | WO1999043300A1 Butorphanol sustained release formulations |
| 09/02/1999 | WO1999033488A3 Adjuvanted vaccine formulation |
| 09/02/1999 | WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 09/02/1999 | WO1999030693A3 A double capsule for the administration of active principles in multiple therapies |
| 09/02/1999 | WO1999027109A3 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/02/1999 | WO1999026632A8 Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
| 09/02/1999 | WO1999015548B1 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2640994A1 Enamel matrix protein composition for preventing or treating infection |
| 09/02/1999 | CA2322175A1 Mucosal microparticle conjugate vaccine |
| 09/02/1999 | CA2321993A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | CA2321991A1 Method for the treatment of pain, including chronic and female specific pain |
| 09/02/1999 | CA2321928A1 Cyclic peptide antifungal agents |
| 09/02/1999 | CA2321924A1 Butorphanol sustained release formulations |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2321114A1 Streptogramin derivatives, preparation method and compositions containing same |
| 09/02/1999 | CA2318762A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials |
| 09/01/1999 | EP0939128A2 New HCV isolates |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0938563A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
| 09/01/1999 | EP0938560A1 GENOMIC NUCLEIC ACIDS, cDNA AND mRNA WHICH CODE FOR POLYPEPTIDES WITH IL-16 ACTIVITY, PROCESSES FOR THE PRODUCTION THEREOF AND THEIR USE |